DIFFUSE ASTROCYTOMA, IDH-MUTANT
Clinical trials for DIFFUSE ASTROCYTOMA, IDH-MUTANT explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE ASTROCYTOMA, IDH-MUTANT trials appear
Sign up with your email to follow new studies for DIFFUSE ASTROCYTOMA, IDH-MUTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for Hard-to-Treat brain cancers
Disease control Recruiting nowThis study tests an experimental oral drug called NEO212 in adults with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it can slow tumor growth. About 134 participants will receive NEO212 a…
Matched conditions: DIFFUSE ASTROCYTOMA, IDH-MUTANT
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Brain tumor patients may get sharper radiation with fewer side effects
Disease control Recruiting nowThis study tests whether proton therapy, which targets tumors more precisely than standard photon radiation, is as effective for people with IDH-mutated grade 2 or 3 gliomas. About 225 adults aged 18-65 will be randomly assigned to receive either proton or photon therapy. The mai…
Matched conditions: DIFFUSE ASTROCYTOMA, IDH-MUTANT
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 19, 2026 11:46 UTC